Russell Hope
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 16
- SARS-CoV-2 and COVID-19 Research 7
-
- Antibiotic Resistance in Bacteria 25
- Co-authors
- Naresh Magan (10 shared papers)David Aldred (5 shared papers)David M. Livermore (27 shared papers)Michel Doumith (12 shared papers)Neil Woodford (15 shared papers)Rosy Reynolds (18 shared papers)Victoria Cairns (1 shared paper)G. Brick (6 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (31 papers)Journal of Hospital Infection (13 papers)Eurosurveillance (6 papers)International Journal of Antimicrobial Agents (5 papers)Clinical Microbiology and Infection (5 papers)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Russell Hope
109 papers receiving 3.9k citations
Russell Hope's Hit Papers
Peers
Comparison fields: 5 of 132
- Molecular Medicine 1.2k
- Applied Microbiology and Biotechnology 357
- Endocrinology 513
- Clinical Biochemistry 356
- Infectious Diseases 910
Countries citing papers authored by Russell Hope
This map shows the geographic impact of Russell Hope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Hope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Hope more than expected).
Fields of papers citing papers by Russell Hope
This network shows the impact of papers produced by Russell Hope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Hope. The network helps show where Russell Hope may publish in the future.
Co-authors
The 25 scholars most cited alongside Russell Hope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Hit paper breakdown → | 2021 | 375 |
| 2 | 2003 | 287 | |
| 3 | 2003 | 243 | |
| 4 | 2005 | 155 | |
| 5 | 2002 | 152 | |
| 6 | 2012 | 152 | |
| 7 | 2002 | 146 | |
| 8 | 2014 | 126 | |
| 9 | 2008 | 103 | |
| 10 | 2010 | 94 | |
| 11 | 2008 | 89 | |
| 12 | 2016 | 86 | |
| 13 | 2009 | 84 | |
| 14 | 2013 | 79 | |
| 15 | 2010 | 78 | |
| 16 | 2015 | 74 | |
| 17 | 2011 | 71 | |
| 18 | 2019 | 62 | |
| 19 | 2003 | 62 | |
| 20 | 2008 | 57 |
About Russell Hope
Russell Hope is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology and Plant Science, having authored 116 papers that have together received 4.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (25 papers), Antimicrobial Resistance in Staphylococcus (16 papers), Antibiotic Use and Resistance (14 papers), Mycotoxins in Agriculture and Food (10 papers), Urinary Tract Infections Management (9 papers), Bacterial Identification and Susceptibility Testing (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Applied Microbiology and Biotechnology (357 citations), Endocrinology (513 citations), Clinical Biochemistry (356 citations) and Infectious Diseases (910 citations). Russell Hope has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include Naresh Magan, David Aldred, David M. Livermore, Michel Doumith, Neil Woodford, Rosy Reynolds, Victoria Cairns, G. Brick, Alan P. Johnson and Shazad Mushtaq. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Eurosurveillance, International Journal of Antimicrobial Agents and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.